drugset / Trial / NCT05795816

Effectiveness of Testofen Compared to Placebo on Long COVID Symptoms

NCT05795816 ↗

Phase 3 Completed 150 enrolled RDC Clinical Pty Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a double blind, randomised, placebo-controlled trial to evaluate orally-dosed Testofen (a specialised extract of Trigonella foenum-graecum (Fenugreek) seed) compared to placebo on post COVID-19 symptoms in otherwise healthy participants 18 years and over.

Timeline

Start
2023-10-25
Primary completion
2025-01-30
Completion
2025-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testofen Unknown 300 mg Oral

Indications